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Abstract 
Breast cancer is one of the top cancer-death causes and specifically accounts for 10.4% of all cancer 
incidences among women. The prediction of breast cancer recurrence has been a challenging 
research problem for many researchers. Data mining techniques have recently received considerable 
attention, especially when used for the construction of prognosis models from survival data. However, 
existing data mining techniques may not be effective to handle censored data. Censored instances are 
often discarded when applying classification techniques to prognosis. In this paper, we propose a 
cost-sensitive learning approach to involve the censored data in prognostic assessment with better 
recurrence prediction capability. The proposed approach employs an outcome inference mechanism 
to infer the possible probabilistic outcome of each censored instance and adopt the cost-proportionate 
rejection sampling and a committee machine strategy to take into account these instances with 
probabilistic outcomes during the classification model learning process. We empirically evaluate the 
effectiveness of our proposed approach for breast cancer recurrence prediction and include a 
censored-data-discarding method (i.e., building the recurrence prediction model by only using 
uncensored data) and the Kaplan-Meier method (a common prognosis method) as performance 
benchmarks. Overall, our evaluation results suggest that the proposed approach outperforms its 
benchmark techniques, measured by precision, recall and F1 score. 
Keywords: Recurrence Prediction, Cost-Sensitive Learning, Survival Analysis, Breast Cancer, Data 
Mining  
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1 INTRODUCTION 
Breast cancer, the most common cancer among women in many countries (Calle 2004), is a malignant 
tumor that develops when cells in the breast tissue divide and grow without the normal controls on 
cell death and cell division (Jerez-Aragonés et al. 2003; Delen et al. 2005). In 2004, breast cancer 
claimed 519,000 lives around the globe. It accounts for 1% of all the deaths in the world (Khan et al. 
2008). In Taiwan, breast cancer is also the first leading cause according to the statistics from Bureau 
of Health Promotion of Taiwan. To improve the efficiency of patient management tasks such as 
diagnosis and treatment planning, the prediction of clinical outcome of patients after breast cancer 
surgery is essential. Various treatment modalities exist for many solid tumor types and their use is 
well established. However, the toxicity of some treatments is often observed. As there is a real risk of 
mortality associated with treatment, it is vital to offer different therapies depending on patient status. 
In this sense, to predict whether a patient will suffer a recurrence of her disease is very important, so 
that the risks and expected benefits of specific therapies can be compared (Jerez-Aragonés et al. 2003). 
Among different prognostic modeling techniques that induce models from medical data, survival 
analysis methods are specific both in terms of modeling and the type of data required (Jerez-Aragonés 
et al. 2003). Data for survival analysis normally include a censor variable, which indicates whether 
some outcome under observation (e.g., recurrence of or death caused by breast cancer) has occurred 
within a certain follow-up period. However, the observation period for some patients may be shorter 
than the prespecified follow-up period and the observed event has not occurred during their 
observation period. Such patients are referred as censored data, because the outcomes (i.e., whether 
the observed event will occur) of these patients are unknown by the end of the follow-up period.  
Traditional statistical techniques, such as Kaplan-Meier analysis and Cox-Propositional hazard 
models have been developed for survival estimation. Those methods, however, suffer from major 
drawbacks in which certain assumptions must be satisfied. For example, the Kaplan-Meier method 
assumes the independence of censoring times, whereas the Cox-Propositional method assumes the 
non-changeable strength of a prognostic factor over time (Ritthipravat 2009; Jerez-Aragonés et al. 
2003).   
With the advancement in the field of data mining (or more specifically machine learning), various 
methods have come into existence. These methods have demonstrated their advantages over 
traditional statistical methods in various domains. For instance, data mining methods have been 
applied to construct various recurrence prediction models in the medical domain (Ali et al. 2009; 
Ohno-Machado 2001; Jerez et al. 2005; Lucas & Abu-Hanna 1999; Zupan et al. 2000). When 
applying a data mining technique to construct a classification model from a survival dataset that 
includes censored data, prior studies typically adopt a simple approach by removing these censored 
data from the survival dataset before the training proceeds. However, this approach decreases the size 
of the dataset for training purpose and, when the amount of censored data is relatively large, will 
degrade the effectiveness of the resultant classification model (Zupan et al. 2000). To address this 
limitation, we propose in this study an approach that allows us to adequately exploit censored data in 
a survival dataset when constructing a recurrence classification model. Specifically, we develop an 
outcome inference mechanism, on the basis of the k-nearest neighbor method, to infer the possible 
outcome of each instance of the censored data as well as to estimate the probability of the inferred 
outcome for each instance. Because these instances in the censored data are associated with 
probabilistic rather than deterministic outcomes, we subsequently employ a cost-sensitive learning 
algorithm to train a classification model from this focal a survival dataset. 
The remainder of this paper is organized as follows. In Section 2, we review common prognosis 
factors for breast cancer, traditional survival analysis methods, and prior studies on using data mining 
methods for breast cancer prognosis. We detail our proposed approach in Section 3. We then detail 
our evaluation design and discuss some important evaluation results in Section 4. We conclude with a 
summary and discussions of the study’s contributions in Section 5. 
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2 LITERATURE REVIEW 
In this section, we review literature related to common prognosis factors for breast cancer, traditional 
survival analysis methods, and prior studies on using data mining techniques for breast cancer 
prognosis. 
2.1 Prognostic Factors for Breast Cancer and Taiwan Cancer Registry 
Prognostic factors are used to aid clinical decision making and help select appropriate treatments for 
individual patients. Most recent decisions for breast cancer patients are made on the basis of 
prognostic and predictive factors. Two main categories of the prognostic factors for breast cancer 
include chronological factors and biological factors. The chronological factors are indicators of how 
long the cancer has been present, and the biological factors are indicators of the potential behavior of 
a tumor. The chronological factors include node status, tumor size, and tumor grade, while the 
biological factors include estrogen receptor and progesterone receptor (Bundred 2001; Delen et al. 
2005). 
The Taiwan Cancer Registry was founded in 1979. Hospitals in Taiwan with greater than 50-bed 
capacity that provide outpatient and hospitalized cancer care were recruited to participate in reporting 
all newly diagnosed cancer cases to the registry. It routinely collects data on patient demographics, 
primary tumor site, tumor morphology and stage at diagnosis, first course of treatment, and follow-up 
for vital status.  
In this study, we use seventeen descriptive variables from Taiwan Cancer Registry for the breast 
cancer recurrence prognosis. The seventeen variables include three patient demographics variables, 
four chronological factor variables, four biological factor variables, and six course-of-treatment 
descriptive variables. Three patient demographic variables include the follow-up duration, age, and 
recurrence status. Four chronological factors are pathological tumor size, number of regional lymph 
nodes, number of regional invaded lymph nodes, and tumor staging. Four biological factors are 
histopathological pattern, degree of cell differentiation, estrogen receptor, and progesterone receptor. 
Finally, six descriptive variables for course of treatment include clearness of surgical margin, 
resection of peripheral lymph node, surgery for primary tumor, chemo therapy, radio therapy, and 
hormone therapy. 
2.2 Traditional Survival Analysis Methods 
Survival analysis methods involve the modeling of time to event data. In medical research, a survival 
analysis method deals with how to estimate the survival of a particular patient suffering from a 
disease over a particular time period. Survival analysis is also a popular tool used in clinical trials 
where it is well suited to deal with incomplete data. Kaplan-Meier analysis (Kaplan & Meier 1958) 
and Cox-Propositional hazard model (Cox 1972) are two well-known conventional statistical 
techniques for survival analysis.  
The Kaplan-Meier analysis is a non-parametric technique for estimating time-related events. In 
medical research, Kaplan-Meier analysis is used to measure the fraction of patients living for a certain 
amount of time after treatment. An important advantage of the Kaplan-Meier analysis is that it 
incorporates information from all of the observations available, both censored and uncensored, by 
considering any point in time as a series of steps defined by the observed survival and censored times. 
In graphical terms, a plot of the proportion of patients surviving against time is a series of horizontal 
steps of declining magnitude (Kaplan & Meier 1958; Utley 2000). The formulation of Kaplan-Meier 
analysis is: Let S(t) be a survival function that gives the probability of surviving or having a lifetime 
exceeding time t. For a sample from this population of size N, let the observed times until experienced 
an event of the N sample members be: t1 ≤ t2 ≤ t3 ≤ … ≤ tN. Corresponding to each ti is ni (i.e., the 
number at risk just prior to time ti) and di (i.e., the number of experienced an event at time ti). The 
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Kaplan-Meier estimator is a nonparametric maximum likelihood estimate of S(t) and is a product of 
the form: S ^(t) = ∏
ti ≤ t
ni − di
ni . 
Cox’s proportional hazards model (Cox 1972) attempts to separate out the time dependent survival 
information from all factors specific to patients. It allows estimating the relationship between 
covariates and a possibly censored failure time. This is achieved by assuming that the time 
dependence of the survival probability can be factored out according to: 
hi(t)= h0(t)exp(Xiβ) 
where hi(t) denotes the hazard for individual i, with attributes Xi , at time t, referred to the observed 
hazard h0(t) of a baseline population which measures the risk of experienced an event at time t.  
2.3 Data Mining Techniques for Breast Cancer Prognosis 
With advances in the field of machine learning (or broadly data mining), a new stream of methods 
have came into existence. These methods generally are proved to be more effective as compared to 
traditional statistical methods (Ohno-Machado 2001). Most data mining techniques employed for 
cancer prediction and prognosis belong to supervised learning. The major types of the data mining 
techniques employed include: artificial neural networks (ANNs), decision trees (DTs), and k-nearest 
neighbor algorithms (Cruz & Wishart 2006).  
ANNs are originally designed to model the way the brain works with multiple neurons being 
interconnected to each other through multiple axon junctions. Just as with biological learning, the 
strength of neural connections is strengthened or weakened through repeated training or reinforcement 
on labeled training data (Rumelhart et al. 1986).  
Tumor-node-metastasis (TNM) staging system is a physician-based expert system for the estimation 
of prognosis of breast cancer patients. The proliferation of factors in breast cancer has lead to clinical 
confusion, but the system just relies heavily on the subjective opinion of a pathologist or expert 
clinician and cannot accommodate these new factors (Burke et al. 1997). Clearly, the TNM system is 
unsatisfactory for optimal-treatment decision-making and for patient counseling. In response, Burke et 
al. (1997) investigated the predictive accuracy of ANNs with the data of breast cancer and colorectal 
cancer in PCE (Patient Care Evaluation) dataset and the breast cancer data in the SEER (Surveillance, 
Epidemiology, and End Results) dataset. Their evaluation results suggest that the ANNs model is 
more accurate than the traditional TNM model on predictive accuracy. De Laurentiis et al. (1999) also 
employed ANNs to develop an automatic prognostic model to predict the relapse probability for 
breast cancer patients. By comparing the performance using a receiver operator characteristic (ROC) 
curve, the developed ANNs model outperforms the classical TNM system on predicting relapse of 
breast cancer. Furthermore, Lundin et al. (1999) also investigated the prediction accuracy of ANNs 
and logistic regression model on breast cancer survival. Their experiment results also show that ANNs 
achieve better prediction performance than the logistic regression model does. 
The design and structure of an ANN should be customized for each application because a simple 
generic ANN architecture can lead to very poor performance or extremely slow training. ANNs are 
considered a black-box technology and it is almost impossible to discern how it performs its 
classification (Cruz & Wishart 2006; Chi et al. 2007; Khan et al. 2008). Unlike neural network, 
decision trees (DTs) have always been praised for comprehensibility of their knowledge 
representation and inference procedures. Moreover, DTs have many advantages: they are simple to 
understand and interpret, they require little data preparation, they can handle various types of 
attributes, and they are efficient in terms of learning and generating robust classifiers. Quinlan’s ID3, 
C4.5, and C5 are popular decision tree algorithms (Ali et al. 2009).  
Delen et al. (2005) compared ANNs, DTs, and logistic regression model for the prediction of breast 
cancer survivability using a large dataset containing more than 200,000 cases. Their evaluation results 
conclude that DTs based on the C5 algorithm is the best classifier in their experimental environment 
and ANNs is the second. Khan et al. (2008) investigated how to use fuzzy logic to extensively 
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increase the effectiveness of DTs on prognosis of breast cancer survivability and proposed a weighted 
and fuzzified decision tree method.  
Jerez-Aragonés et al. (2003) proposed a new technique that is a combination DT and ANN for 
prognosis of breast cancer relapse. They consider that the strength of the prognostic factor is not the 
same at different time interval, and classify the original 1035 patients into ‘‘relapse’’ and 
‘‘nonrelapse’’ classes for each time interval to deal with the censoring problem. The DT in the 
combined model is used for the selection of the most relevant prognostic factors for each time interval. 
Subsequently, the ANN at each time interval in the combined model takes as inputs these selected 
variables to reach good prediction performance. 
3 DESIGN OF THE COST-SENSITIVE LEARNING APPROACH 
We propose a cost-sensitive learning approach for breast-cancer recurrence prediction. In order to 
utilize the information of censored data, we take such data uncertainty as the cost of misclassification. 
Based on the cost-proportionate rejection sampling, we can build a committee machine with better 
prediction capability. As we show in Figure 1, the proposed cost-learning approach comprises two 
main phases, including outcome inference for censored data and cost-sensitive learning for 
constructing a prediction model. The particular problem of censored data used for building a 
prediction model is that the follow-up of some patients is too short to determine definite outcomes for 
these patients. When we build a prediction model for a specific time t, the outcomes of the patients 
with follow-up time less than t are considered as uncertain, and these cases traditionally are discarded 
by prior studies employing data mining techniques when constructing a classification model. With a 
given prediction time t, we need to split the training dataset into two groups: the first group consists of 
patients without recurrence and tracked less than t after their operations and patients in the second 
group are followed-up more than t (i.e., uncensored data). Obviously, the recurrent status of first 
group (i.e., censored data) is uncertain and we need to estimate the probability of their possible 
outcomes before the construction of a prediction model. As for the second group (i.e., uncensored 
data), their outcomes are definite (either with the status of non-recurred or recurred). Accordingly, the 
outcome inference phase estimates the recurrence probability of each instance in the censored data on 
the basis of its nearest neighbors in the uncensored data. Subsequently, with the consideration of the 
censored data that are associated with probabilistic rather than deterministic outcomes, we then 
employ the cost-proportionate rejection sampling to construct several classifiers. Therefore, we are 
able to conduct predictions in a committee-decision manner. In the following, we detail the design of 
each phase in our proposed approach. 
3.1 Outcome Inference phase 
In the outcome inference phase, we infer the possible outcome for each instance in the censored data 
by calculating its distance to all instances in the uncensored data. The distance between an instance ci 
in the censored data and an instance nj in the uncensored data is estimated by the following equation: 
( )( )∑
=
×−×=
k
r
rjrirrji fnAcAwnc
1
)()(),(distance  
where Ar(ci) is the value of attribute r for the censored instance ci, Ar(nj) is the value of attribute r for 
the uncensored instance nj, wr is a weighted function for attribute r, and fr is the scale normalization 
function for attribute r to ensure that the distance between ci and nj with respect to attribute r lies 
between 0 and 1. In this study, the weighted function for attribute r (i.e., wr) is estimated by the gain-
ratio measure derived from the set of uncensored instances in the input training dataset. 
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Figure 1 Overall Process of the Proposed Approach 
Once the distances between the censored instance ci and all uncensored instances are estimated, we 
then select neighbors (from the uncensored instances) for ci. Specifically, given a prespecified 
distance threshold δ, we select those uncensored instances whose distances with ci are no greater than 
δ as the neighbors of ci. Assume that the average distance of ci to the selected neighbors pertaining to 
the recurrent class is dist_R and the average distance to the selected neighbors belonging to the non-
recurrent class is dist_NR. By comparing dist_R and dist_NR, ci is assigned to the closest class. We 
not only infer the possible outcome for ci but also assign a probability cf(ci) to the inferred class. In 
this study, cf(ci) is calculated as follows: 
cf(ci) =  
⎩⎨
⎧1 – dist_Rtot_dist  if ci is assigned to the recurrent class R
1 – 
dist_NR
tot_dist  if ci is assigned the non-recurrent class NR.
 
where dist_R = 
a
ai
nof
nc
#
),distance(∑ , na denotes a selected neighbor belonging to the recurrent class R, 
dist_NR = 
b
bi
nof
nc
#
),distance(∑ , na denotes a selected neighbor belonging to the non-recurrent class 
NR, tot_dist = dist_R + dist_NR. For each na and nb, distance(ci, na) ≤ δ  and distance(ci, nb) ≤ δ. 
3.2 Cost-sensitive Learning phase 
The construction of an automated recurrent prediction model with the expansion of the censored 
instances with differential outcome probabilities resembles cost-sensitive learning that performs 
learning to build an ensemble classifier against training data with non-uniform distribution weights 
(Zadrozny et al. 2003). Several cost-sensitive learning methods have been proposed in the literature 
(Domingos 1999; Drummond & Holte 2000; Fan et al. 1999, Margineantu 2002; Zadrozny et al. 
2003); among them, applying a sampling method to sample training instances from the original 
training dataset—on the basis of their respective outcome probabilities—and use them to construct an 
automated classifier with an appropriate classification learning algorithm seems effective and 
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computationally efficient. By doing so, we can transform a cost-sensitive learning problem to a cost-
insensitive learning task (Zadrozny et al. 2003). 
We accordingly adopt this method in our cost-sensitive learning phase, wherein our approach 
performs two tasks: censored data sampling and classifier learning. Specifically, for the censored data 
sampling, the proposed approach employs the cost-proportionate rejection sampling (Von Neumann 
1951) to randomly select from the set of censored instances and include them for training purpose. 
When deciding whether to include a censored instance ci, the cost-proportionate rejection sampling 
first generates a random number ri ranging from 0 to 1 and then compares with the acceptance 
probability cf(ci)/Z of the instance under evaluation, where Z is a predefined constant. As suggested 
by Zadrozny et al. (2003), the constant Z is often assigned as the maximal cf(ci) value across all 
censored instances. A censored instance ci will be excluded from the sample if ri is larger than its 
acceptance probability, or be included otherwise. In addition, for all uncensored instances, because 
they are associated with definite outcomes (non-recurrent or recurrent), we thus include all of them in 
the sample. 
Furthermore, our approach adopts a committee machine strategy; i.e., we repeat the abovementioned 
sampling process k times to generate k sets of training samples. For each set of training samples, we 
perform the classifier learning task. Specifically, we employ C4.5 as the underlying learning 
algorithm to construct a classifier for each given set of training samples. As a result, k classifiers are 
generated and together form a committee to give a recurrence warning for a patient after operation if 
more than half of the classifiers predict that recurrence event will happen. 
4 EMPIRICAL EVALUATION AND RESULTS 
We empirically evaluate the effectiveness of our proposed approach using 224 breast cancer cases 
collected from a tertiary medical center in northern Taiwan. Our evaluation includes a censored-data-
discarding method (i.e., employing C4.5 to build a recurrence prediction model by only using 
uncensored data) and the Kaplan-Meier method (a common prognosis method) as performance 
benchmarks. In the following, we detail the data collection and evaluation design and then discuss 
important evaluation results. 
4.1 Data Collection  
We collected 362 operation cases, which were clinically administered between January 2004 and 
December 2006 at a tertiary medical center in northern Taiwan. Subsequently, we performed a data 
cleaning procedure in which 138 incomplete cases were deleted. As a result, the dataset for our 
empirical evaluation involves 224 cases without missing attribute values. Each case is described with 
17 variables recorded in the cancer registry database of Bureau of Health Promotion, Taiwan. The 17 
variables are the follow-up duration, age, histopathological pattern, degree of Cell differentiation, 
pathological tumor size, number of regional lymph nodes, clearness of surgical margin, tumor 
staging, estrogen receptor, progesterone receptor, resection of peripheral lymph node, surgery 
for primary tumor, chemotherapy, radiotherapy, and recurrence (used to determine outcome 
classes with respect to a specific time t). Table 1 provides a summary of the descriptive 
statistics of our cases.  
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Variables Range/Encoding scheme Descriptive statistics 
Follow-up time (in months) 3 to 22 μ = 12.42; σ = 3.35 
Age (in years)  25 to 87 μ = 52.67; σ = 11.55 
Histopathological pattern 0: Carcinoma in situ 1: Invasive carcinoma 
0 :12;  
1 :212 
Degree of Cell differentiation 
1: Well differentiated 
2: Medium differentiated 
3: Poor differentiated 
4: Undifferentiated 
1:17; 
2: 152; 
3: 50; 
4: 5 
Pathological tumor size 0 to 18 μ = 2.87; σ = 2.00 
Number of regional lymph nodes 0 to 96 μ = 11.96; σ = 9.44 
Number of regional invaded lymph nodes 0 to 32 μ = 2.40; σ = 4.87 
Clearness of Surgical margin No, Yes No:34; Yes:190 
Tumor staging Stage 0 to Stage IV  0:11; I:79;  II: 93; III: 31; IV: 10 
Estrogen receptor  No, Yes No:55; Yes: 169 
Progesterone receptor No, Yes No: 64; Yes: 160 
Resection of peripheral lymph node No, Yes No: 43; Yes: 181 
Surgery for primary tumor No, Yes No: 28; Yes: 196 
Chemotherapy No, Yes No: 107; Yes: 117 
Radiotherapy No, Yes No: 176; Yes: 48 
Hormone therapy No, Yes No:37; Yes:187 
Recurrence No, Yes No:201; Yes:23 
Table 1: Summary of Attributes of Our Breast Cancer Cases 
4.2 Evaluation Design 
The particular characteristic of survival data is that for some patients the follow-up is too short to 
determine a definite outcome. In this study, we want to predict the recurrence status of the breast 
cancer patient after 12 months of the operation. First, We divide the dataset into two groups: the first 
group (i.e., censored data) consists of non-recurrent patients with follow-up less than 1 year (i.e. their 
one-year recurrent outcomes are uncertain), the second group are the uncensored data that contain 
non-recurrent cases tracked for more than 1 year after receiving operation (they are assumed to be 
non-recurrent cases under 1 year prediction setup) and recurrent cases in which patients whose 
recurrences have been observed within 1 year window. Accordingly, 108 instances in our 224 
collected cases dataset are censored instances and 116 are uncensored instances (101 non-recurrent 
cases and 15 recurrent cases respectively). 
We use a stratified three-fold cross-validation strategy to evaluate our proposed cost-sensitive 
learning method and the two benchmark methods, including the censored-data-discarding method and 
the Kaplan-Meier method. The cross-validation strategy divides the original dataset into three subsets 
of approximately equal size and equal distribution of recurrent and non-recurrent cases. Accordingly, 
each subset is used for testing purpose and the other two subsets are employed for training purpose. 
To minimize potential biases resulting from the randomized sampling as well as to obtain more 
reliable performance estimates, we perform the three-fold cross-validation process 10 times. That is, 
the effectiveness of each technique under investigation is obtained by averaging the performance 
recorded from the 30 trials. 
We evaluate the effectiveness of each technique by examining its prediction of recurrence’s precision, 
recall, and F1 score (Rijsbergen 1979), as follows: 
F1 = 2×Precision×RecallPrecision+Recall  
where Precision = TPTP+FP, Recall = 
TP
TP+FN , TP represents the number of testing instances correctly 
classified as in the recurrent class, TN denotes the number of testing instances correctly classified as 
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in the non-recurrent class, FP is the number of testing instances incorrectly classified as in the 
recurrent class, FN denotes the number of testing instances incorrectly classified as in the non-
recurrent class. 
4.3 Evaluation Results  
We conduct a series of parameter-tuning experiments to select an optimal configuration of parameter 
values required by the proposed technique. Specifically, our proposed technique involves two 
parameters: δ (i.e., distance threshold for selecting neighbors for each censored instance in the 
outcome inference phase) and k (i.e., the number of classifiers to construct in the cost-sensitive 
learning phase). 
We first set k to 15 and examine δ between 0.2 to 0.8 in increments of 0.1. When setting δ to 0.6, our 
proposed technique reaches the highest F1 value. Thus, we employ 0.6 for δ in subsequent 
experiments. We then investigate k between 7 and 55 in increments of 4. Our tuning-experiment result 
suggests that the best F1 value is achieved when setting k as 15.  
For the Kaplan-Meier method, we use the threshold of 0.5 to determine the predicted class for each 
testing instance. That is, the testing instances with Kaplan-Meier estimators higher than 0.5 are 
predicted as in the non-recurrent class, otherwise the recurrent class. As summarized in Table 2, our 
proposed technique outperforms the censored-data-discarding method and the Kaplan-Meier method 
in all evaluation metrics investigated (i.e., F1 score, recall, and precision for the recurrent classes). 
Because the non-recurrent class represents the majority class in our dataset (i.e., 108 non-recurrent 
cases v.s. 15 recurrent cases), such class asymmetry biases the prediction of the Kaplan-Meier method, 
whose prediction is based on conditional probability. On the other hand, the censored-data-discarding 
method based on C4.5 is able to mitigate the bias causing by overwhelming majority with its learning 
ability. Furthermore, our evaluation results demonstrate the utility of the censored data for improving 
the prediction effectiveness. Particularly, the recurrence prognosis effectiveness attained by our 
proposed technique is at least two times higher than that of traditional censored-data-discarding 
method. We further test the performance differences by two-tails t-test examinations. As we illustrate 
in Table 3, our proposed cost-sensitive learning approach significantly outperforms the censored-data-
discarding method and the Kaplan-Meier method. 
 
Technique F1 (%) Recall (%) Precision (%) 
Cost-Sensitive Learning  34.51 29.33 41.90 
Censored-Data-Discarding 6.63 4.00 19.35 
Kaplan–Meier 0.00 0.00 0.00 
Table 2: Comparative Evaluation Results 
 
 Cost-Sensitive Learning 
Censored-Data 
Discarding Kaplan-Meier 
Cost-Sensitive Learning    
Censored-Data Discarding 0.00***   
Kaplan-Meier 0.00*** 0.028**  
***: Significant at p < 0.01 on a two-tailed t-test; **: Significant at p < 0.05 on a two-tailed t-test. 
Table 3: Significance Test on F1 between Different Techniques 
5 CONCLUSION 
It is always helpful to make individualized prognosis for patients regarding disease management. 
According to patient’s physical characteristics and disease progress, treatment plan and drug 
prescription may vary. In terms of cancer incidence, it is crucial to take active therapies with better 
understanding of recurrence status. However, typical prediction models are usually limited to the 
utilization of censored data and may result in an unsatisfactory predictive capability. In this study, we 
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propose a cost-sensitive learning approach to leverage censored data for classification model learning. 
With a given prediction time, the nearest-neighbor algorithm is employed to estimate the recurrent 
status (and its probability) of each censored instance. Therefore, we can take the speculative 
recurrence probability as the cost of misclassification and build a committee-decision prediction 
model. Our empirical results reveal that our cost-sensitive learning approach has better prediction 
capabilities in terms of precision, recall and F1 score than the two benchmark techniques. 
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